Landiolol in Mitral Valve Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 28, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Cardiac FailureLow Cardiac Output Syndrome
Interventions
DRUG

Landiolol

Intravenous infusion of landiolol

DRUG

Placebo

Intravenous infusion of saline solution of NaCl 0.9%

Trial Locations (5)

15121

RECRUITING

Ospedale Cesare Arrigo, Alessandria

20132

RECRUITING

Ospedale San Raffaele, Milan

95123

RECRUITING

"Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San Marco", Catania

Unknown

RECRUITING

A. O. Ordine Mauriziano di Torino, Torino

RECRUITING

Azienda Universitario-Ospedaliera O.O.R.R., Foggia

All Listed Sponsors
lead

Università Vita-Salute San Raffaele

OTHER

NCT06793670 - Landiolol in Mitral Valve Surgery | Biotech Hunter | Biotech Hunter